Search results for "Brain Infarction"

showing 7 items of 17 documents

Sudden sensorineural hearing loss as prodromal symptom of anterior inferior cerebellar artery infarction.

2011

Sudden sensorineural hearing loss is a clinical condition characterized by a sudden onset of unilateral or bilateral hearing loss. In recent years sudden deafness has been frequently described in association with anterior inferior cerebellar artery (AICA) infarction generally presenting along with other brainstem and cerebellar signs such as ataxia, dysmetria and peripheral facial palsy. The authors report a rare clinical case of a 53-year-old man who suddenly developed hearing loss and tinnitus without any brainstem or cerebellar signs. Computed tomography of his brain was normal, and the audiological results localized the lesion causing deafness to the inner ear. Surprisingly, magnetic re…

Brain InfarctionMalemedicine.medical_specialtyAnterior inferior cerebellar artery infarctionAtaxiaHearing lossHearing Loss SensorineuralInfarctionLesionSudden deafneCerebellar DiseasesInternal auditory arteryDysmetriamedicine.arteryInternal medicineCerebellumInner earotorhinolaryngologic diseasesmedicineVertebrobasilar InsufficiencyHumansbusiness.industrySettore MED/37 - NeuroradiologiaMiddle Agedmedicine.diseaseMagnetic Resonance ImagingSudden deafness; Anterior inferior cerebellar artery infarction; Internal auditory artery; Inner earSettore MED/32 - AudiologiaSurgeryAnterior inferior cerebellar arterymedicine.anatomical_structureOtorhinolaryngologyEar InnerAcute DiseaseCardiologySettore MED/26 - Neurologiamedicine.symptomCerebellar arterybusinessTinnitusORL; journal for oto-rhino-laryngology and its related specialties
researchProduct

Ocular tilt reaction: a clinical sign of cerebellar infarctions?

2009

Ocular tilt reaction (OTR) consists of head tilt, ocular torsion (OT), and skew deviation (SKD) combined with perceptual tilts such as deviations of the subjective visual vertical (SVV). Few case reports have shown that OTR also occurs in patients with cerebellar infarctions.1–4 However, no systematic clinical studies are available on the frequency of signs of OTR in patients with cerebellar lesions. Therefore, the questions arose as to whether OTR is a common clinical sign of an acute cerebellar lesion and whether the time course of its components is similar to those from brainstem infarctions. The cerebellar structures involved in 31 patients were studied in detail elsewhere.5 ### Methods…

Brain InfarctionMalemedicine.medical_specialtyCerebellar lesionsSensitivity and SpecificityCentral nervous system diseaseCerebellar DiseasesTilt-Table Testmedicine.arteryCerebellummedicineSkew deviationHumansAgedAged 80 and overmedicine.diagnostic_testVascular diseasebusiness.industryVision TestsReproducibility of ResultsMiddle AgedVestibular Function Testsmedicine.diseaseSurgeryAnterior inferior cerebellar arteryElectronystagmographyFemaleNeurology (clinical)RadiologyOcular tilt reactionBrainstembusinessNeurology
researchProduct

MitoKATP-channel opener protects against neuronal death in rat venous ischemia.

2005

OBJECTIVE: Mitochondrial adenosine triphosphate-dependent potassium (mitoK ATP ) channels are present in the brain, and several reports have shown their neuroprotective, preconditioning effect against an ischemic insult. The role of mitoK ATP channels in the penumbra area has not been studied thoroughly. In a model of venous ischemia, widespread penumbra-like low flow areas are created, which are susceptible to cortical spreading depression. Thus, we studied effects of mitoK ATP channels on infarct size in this model. METHODS: Male Wistar rats were subjected to two-vein occlusion by photochemical thrombosis of two adjacent cortical veins combined with KCI-induced cortical spreading depressi…

Brain InfarctionMalemedicine.medical_specialtyPotassium ChannelsPhotochemistryIschemiaBrain EdemaPotassium ChlorideIschemiaInternal medicinemedicineDiazoxideLaser-Doppler FlowmetryAnimalsChannel blockerDrug InteractionsRats WistarNeuronsAnalysis of VarianceCell Deathbusiness.industryPenumbraCortical Spreading DepressionDiazoxidemedicine.diseaseCerebral VeinsPotassium channelRatsTolerance inductionDisease Models AnimalNeuroprotective AgentsCerebral blood flowRegional Blood FlowAnesthesiaCortical spreading depressionCardiologySurgeryNeurology (clinical)businessHydroxy AcidsAnti-Arrhythmia AgentsDecanoic Acidsmedicine.drugNeurosurgery
researchProduct

Revascularisation of a Giant Coronary Artery Aneurysm in Suspected Incomplete Kawasaki-Disease

2006

Kawasaki disease leads to typical vascular complications in up to 20 % of untreated cases. We describe a 47-year-old patient with coronary vessel disease, involving the right coronary artery with a huge aneurysmatic dilatation, suspicious for an incomplete form of Kawasaki disease. We found little information about the surgical treatment and postoperative course of this disease in adults. Typically, these infrequent patients present with acute myocardial infarction and require interdisciplinary decision-making.

Brain InfarctionPulmonary and Respiratory Medicinemedicine.medical_specialtyMyocardial InfarctionDiseaseMucocutaneous Lymph Node SyndromeCoronary AngiographyPostoperative ComplicationsAneurysmInternal medicinemedicine.arterymedicineHumanscardiovascular diseasesMyocardial infarctionCoronary Artery BypassSurgical treatmentCoronary artery aneurysmbusiness.industryCoronary ThrombosisCoronary AneurysmMiddle Agedmedicine.diseaseAortic DissectionIntracranial EmbolismRight coronary arteryCoronary vesselCardiologySurgeryKawasaki diseaseCardiology and Cardiovascular MedicinebusinessThe Thoracic and Cardiovascular Surgeon
researchProduct

Incidence and anatomy of gaze-evoked nystagmus in patients with cerebellar lesions.

2011

Background: Disorders of gaze-holding—organized by a neural network located in the brainstem or the cerebellum—may lead to nystagmus. Based on previous animal studies it was concluded that one key player of the cerebellar part of this gaze-holding neural network is the flocculus. Up to now, in humans there are no systematic studies in patients with cerebellar lesions examining one of the most common forms of nystagmus: gaze-evoked nystagmus (GEN). The aim of our present study was to clarify which cerebellar structures are involved in the generation of GEN. Methods: Twenty-one patients with acute unilateral cerebellar stroke were analyzed by means of modern MRI-based voxel-wise lesion-behavi…

Brain Infarctiongenetic structuresNystagmusFlocculusCerebellar lesionsNystagmus PathologicCerebellummedicineGaze evoked nystagmusHumansIn patientBiventer lobuleeducationeducation.field_of_studybusiness.industryAnatomyMiddle AgedMagnetic Resonance ImagingElectrooculographymedicine.anatomical_structureTonsilNeurology (clinical)Brainstemmedicine.symptombusinessNeuroscienceNeurology
researchProduct

In vivo and ex vivo magnetic resonance spectroscopy of the infarct and the subventricular zone in experimental stroke

2015

Ex vivo high-resolution magic-angle spinning (HRMAS) provides metabolic information with higher sensitivity and spectral resolution than in vivo magnetic resonance spectroscopy (MRS). Therefore, we used both techniques to better characterize the metabolic pattern of the infarct and the neural progenitor cells (NPCs) in the ipsilateral subventricular zone (SVZi). Ischemic stroke rats were divided into three groups: G0 (non-stroke controls, n = 6), G1 (day 1 after stroke, n = 6), and G7 (days 6 to 8 after stroke, n =12). All the rats underwent MRS. Three rats per group were analyzed by HRMAS. The remaining rats were used for immunohistochemical studies. In the infarct, both techniques detect…

In vivo magnetic resonance spectroscopyBrain InfarctionMalePathologymedicine.medical_specialtyMRSspectroscopyMagnetic Resonance SpectroscopyTime FactorsHRMASSubventricular zoneRats Sprague-DawleyIn vivoLateral VentriclesmedicineAnimalsStrokebusiness.industryNeurogenesismedicine.diseasestrokeNeural stem cellRatsStrokeneurogenesisDisease Models Animalmedicine.anatomical_structureNeurologyBiomarker (medicine)Original ArticleNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessNeuroscienceEx vivoBiomarkers
researchProduct

Neuroprotection by erythropoietin administration after experimental traumatic brain injury.

2007

A large body of evidence indicates that the hormone erythropoietin (EPO) exerts beneficial effects in the central nervous system (CNS). To date, EPO's effect has been assessed in several experimental models of brain and spinal cord injury. This study was conducted to validate whether treatment with recombinant human EPO (rHuEPO) would limit the extent of injury following experimental TBI. Experimental TBI was induced in rats by a cryogenic injury model. rHuEPO or placebo was injected intraperitoneally immediately after the injury and then every 8 h until 2 or 14 days. Forty-eight hours after injury brain water content, an indicator of brain edema, was measured with the wet-dry method and bl…

MaleTime FactorsBrain EdemaFunctional LateralityRats Sprague-Dawleychemistry.chemical_compoundTraumatic brain injuryMedicineAnalysis of Variance Animals Blood-Brain Barrier; drug effects Brain Edema; drug therapy/etiology Brain Infarction; drug therapy/etiology Brain Injuries; complications/drug therapy Disease Models; Animal Erythropoietin; administration /&/ dosage Evans Blue; diagnostic use Functional Laterality Humans Male Neurologic Examination Neuroprotective Agents; administration /&/ dosage Rats Rats; Sprague-Dawley Reaction Time; drug effects Recombinant Proteins Time Factorsadministration /&/ dosageSpinal cord injuryEvans BlueNeurologic ExaminationGeneral Neuroscienceexperimental models of brain and spinal cord injuryExtravasationNeuroprotectionRecombinant Proteinsmedicine.anatomical_structureNeuroprotective AgentsBlood-Brain BarrierAnesthesiadiagnostic usemedicine.drugEvans BlueBrain InfarctionTraumatic brain injuryCentral nervous systemrecombinant human EPO (rHuEPO)PlaceboNeuroprotectionReaction TimeAnimalsHumansMolecular BiologyErythropoietinAnalysis of VarianceNeuroscience (all)business.industryAnimaldrug therapy/etiologymedicine.diseaseRatsDisease Models AnimalchemistryErythropoietindrug effectsBrain InjuriesDisease Modelsrecombinant human EPO (rHuEPO); experimental models of brain and spinal cord injury; NeuroprotectionNeurology (clinical)Sprague-Dawleybusinesscomplications/drug therapyDevelopmental BiologyBrain research
researchProduct